Prognostic value of lymphocyte count, NLR and PLR on admission for COVID-19 patients at Tishreen University Hospital in Lattakia

Authors

  • Firas Hussein Tishreen University

Abstract

Background: Since December 2019, Coronavirus has been spreading widely until it became a fatal global pandemic. We’re currently in a great need to determine early and effective predictive biomarkers for the severity and mortality, in order to understand the pathophysiological mechanisms of the disease, and to find better treatment approaches.

Object: Studying the relationship between lymphocyte count, neutrophil to lymphocyte ratio(NLR) and the platelet to lymphocyte ratio (PLR)  and clinical and radiologic severity , mortality rate in patients with COVID-19 on admission. Methods: Prospective cohort study, Samples were collected from the COVID department of Tishreen University Hospital in Latakia from May 2020 to December 2020. Samples were sequentially included according to admission date based on the results of COVID-19 nasal swab test, characterization of demographic variables (age and gender), clinical and radiologic severity upon admission, in addition to the laboratory results. Patients' clinical progress was followed up during hospitalization, as well as their need for supportive oxygen (invasive and non-invasive mechanical ventilation) and the occurrence of complications during hospitalization. Finally, we listed the cases of recovery and death. Results: The sample included 284 patients. 194 males and 90 females. Patients aged between 27 and 92 years, with a mean age of 65. Each variable was studied in relation to clinical,  radiologic severity and death. We found that lymphocytopenia on admission was associated with an increased clinical severity
(P-value = 0.002) and a higher mortality (P-value = 0.02). A higher neutrophil to lymphocyte ratio was associated with an increased clinical and radiologic severity, and a higher mortality
(P-value = 0.0001). As for the increase in the platelet to lymphocyte ratio, it was associated with a more severe illness; clinically (P-value = 0.0001) and radiologically (P-value = 0.0001), as well as a higher mortality (P-value = 0.006).

Conclusion: Comprehensive laboratory tests must be performed for COVID patients upon admission; the most important of which are: WBC – Lumphocyte count  – NLR – PLR. This helps to identify high risk patients in order to provide them with early intensive care, as they’re more likely to develop severe respiratory complications. Regular

radiologic scanning (Chest CT with contrast – Doppler ultrasonography) should also be performed to detect these complications early and treat them appropriately.

Downloads

Published

2023-09-13

How to Cite

1.
فراس حسين. Prognostic value of lymphocyte count, NLR and PLR on admission for COVID-19 patients at Tishreen University Hospital in Lattakia. Tuj-hlth [Internet]. 2023Sep.13 [cited 2024Nov.24];45(4):47-59. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/16047

Issue

Vol. 45 No. 4 (2023): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

Most read articles by the same author(s)